Solid Biosciences raises ~$240M in private placement; prelim cash ~$188M

Solid Biosciences Inc.

Gross proceeds ~$240M from 14.97M shares at $5.61 and 27.81M pre-funded warrants at $5.609.
Preliminary cash, equivalents and securities ~$187.9M as of Dec 31, 2025 (unaudited).
Net proceeds extend runway into H1 2028; funds pipeline development, BD, and G&A.
Investors include Perceptive Advisors, Bain Capital Life Sciences, RA Capital Management, Invus, and others.
Private placement expected to close March 9, 2026; Leerink and Citi lead placement agents.

item 1.01 item 2.02 item 3.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Solid Biosciences Inc. entered into Securities Purchase Agreement with certain institutional accredited investors valued at approximately $240.0 million (effective 2026-03-06).

Action: entry
Agreement: equity purchase
Counterparty: certain institutional accredited investors
Value: approximately $240.0 million
Effective: 2026-03-06

Exact text from the filing

On March 6, 2026, Solid Biosciences Inc., a Delaware corporation (the “ Company ”), entered into a securities purchase agreement (the “ Securities Purchase Agreement ”) with certain institutional accredited investors (the “ Investors ”), pursuant to which the Company agreed to issue and sell to the Investors in a private placement an aggregate of 14,973,257 shares of the Company’s common stock, par value $0.001 per share (the “ Shares ”), at a price of $5.61 per share, and, to investors who so choose in lieu of Shares, pre-funded warrants to purchase 27,807,482 shares of the Company’s common stock (the “ Pre-Funded Warrants ”), at a price of $5.609 per Pre-Funded Warrant (the “ Private Placement ”).

View on SEC.gov

336 material agreements filed in the last 30 days. Browse all material agreements →

Solid Biosciences Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-096709

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.